BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 306 filers reported holding BLUEBIRD BIO INC in Q1 2018. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $564,000 | +15.6% | 17,637 | +95.0% | 0.05% | +54.8% |
| Q3 2020 | $488,000 | -69.5% | 9,046 | -65.5% | 0.03% | -72.1% |
| Q2 2020 | $1,599,000 | +18.9% | 26,194 | -10.5% | 0.11% | +13.3% |
| Q1 2020 | $1,345,000 | -5.3% | 29,254 | +266.9% | 0.10% | -37.2% |
| Q4 2017 | $1,420,000 | +383.0% | 7,973 | +184.8% | 0.16% | +95.0% |
| Q2 2017 | $294,000 | -67.1% | 2,800 | -86.7% | 0.08% | -23.8% |
| Q1 2016 | $893,000 | -44.7% | 21,000 | +118.8% | 0.10% | -42.0% |
| Q2 2015 | $1,615,000 | +199.6% | 9,600 | +115.0% | 0.18% | +229.1% |
| Q1 2015 | $539,000 | – | 4,465 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6,335,528 | $40,104,000 | 4.92% |
| qPULA Trading Management LP | 14,344 | $91,000 | 0.80% |
| Frazier Life Sciences Management, L.P. | 1,440,757 | $9,120,000 | 0.70% |
| Ikarian Capital, LLC | 462,628 | $2,928,000 | 0.58% |
| Birchview Capital, LP | 98,000 | $620,000 | 0.44% |
| HealthCor Management, L.P. | 455,000 | $2,880,000 | 0.36% |
| Financial Advocates Investment Management | 45,071 | $3,538,000 | 0.29% |
| PDT Partners, LLC | 262,767 | $1,663,000 | 0.25% |
| Monaco Asset Management SAM | 80,000 | $506,000 | 0.19% |
| Summit X, LLC | 103,424 | $651,000 | 0.19% |